Determinants of visit-to-visit systolic blood pressure variability among Ghanaians with hypertension and diabetes mellitus
CONCLUSION: Several socio-demographic and clinical factors are associated with SBPV. Future studies should assess the contribution of SBPV to CVD outcomes among indigenous Africans and identify actionable targets.FUNDING: Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi (each a Participant Company) and the Bill and Melinda Gates Foundation (collectively, the Funders) through the New Venture Fund (NVF). FSS and BO are also supported by funding from the National Heart, Lung, and Blood Institute (R01HL152188).PMID:37576371 | PMC:PMC10416271 | DOI:10.4314/gmj.v57i1.5
Source: Ghana Medical Journal - Category: African Health Authors: Fred S Sarfo Nana K Ayisi-Boateng Samuel B Nguah Osei Sarfo-Kantanka Collins Kokuro Hanson Ababio Yaw Adu-Boakye Bruce Ovbiagele Source Type: research
More News: African Health | Cardiology | Diabetes | Diabetes Mellitus | Education | Endocrinology | Ghana Health | Heart | Hydralazine | Hypertension | Pfizer | Study | Universities & Medical Training